Pharmaceuticals (784) | Uncategorized (784)

Browse by Company

Acacia Diversified Holdings, Inc. (1)
ACELRX PHARMACEUTICALS INC (6)
Acer Therapeutics Inc. (2)
Aclaris Therapeutics, Inc. (3)
Acreage Holdings, Inc. (10)
Adamis Pharmaceuticals Corp (1)
ADIAL PHARMACEUTICALS, INC. (6)
AERIE PHARMACEUTICALS INC (5)
Aerpio Pharmaceuticals, Inc. (2)
AGILE THERAPEUTICS INC (2)
Akorn (8)
ALIMERA SCIENCES INC (4)
Allergan, plc (3)
Amag Pharmaceuticals (2)
Amneal Pharmaceuticals, Inc. (2)
Amphastar Pharma (2)
Ampio Pharmaceuticals, Inc. (2)
ANI Pharma Inc (2)
Applied BioSciences Corp. (1)
APRICUS BIOSCIENCES, INC. (6)
Aquestive Therapeutics, Inc. (2)
ARADIGM CORP (1)
ARVINAS, INC. (4)
Assertio Therapeutics, Inc (1)
AVADEL PHARMACEUTICALS PLC (1)
AVENUE THERAPEUTICS, INC. (3)
Axsome Therapeutics, Inc. (3)
Bakhu Holdings, Corp. (6)
Baudax Bio, Inc. (6)
Bausch Health Companies Inc. (2)
Bespoke Extracts, Inc. (6)
BIODELIVERY SCIENCES INTERNATIONAL INC (5)
BioPharmX Corp (9)
BODY & MIND INC. (5)
Boston Therapeutics, Inc. (1)
Bristol-Myers Squibb (6)
Canbiola, Inc. (15)
Cannabics Pharmaceuticals Inc. (6)
CANNAPHARMARX, INC. (2)
Canopy Growth Corp (2)
Cara Therapeutics, Inc. (2)
CASSAVA SCIENCES INC (1)
Catalent Inc (9)
Cerecor Inc. (7)
CHIASMA, INC (1)
CHINA PHARMA HOLDINGS, INC. (5)
Citius Pharmaceuticals, Inc. (3)
Clearside Biomedical, Inc. (4)
CLS Holdings USA, Inc. (2)
Cocrystal Pharma, Inc. (2)
COLLEGIUM PHARMACEUTICAL, INC (2)
ContraVir Pharmaceuticals, Inc. (1)
CorMedix Inc. (2)
Cronos Group Inc. (2)
CUMBERLAND PHARMACEUTICALS INC (1)
Cure Pharmaceutical Holding Corp. (5)
CymaBay Therapeutics, Inc. (4)
DURECT CORP (2)
Elanco Animal Health Inc (4)
ELITE PHARMACEUTICALS INC (4)
Endo International plc (8)
EPHS HOLDINGS, INC. (1)
Eton Pharmaceuticals, Inc. (7)
Evofem Biosciences, Inc. (6)
Evoke Pharma Inc (1)
Evolus, Inc. (3)
Exactus, Inc. (3)
EYEGATE PHARMACEUTICALS INC (5)
EYENOVIA, INC. (4)
EyePoint Pharmaceuticals, Inc. (4)
FRONTIER OILFIELD SERVICES INC (1)
Fulcrum Therapeutics, Inc. (1)
Gala Pharmaceutical Inc. (1)
GB SCIENCES INC (2)
GREEN HYGIENICS HOLDINGS INC. (7)
GW PHARMACEUTICALS PLC (8)
HARROW HEALTH, INC. (4)
Horizon Pharma plc (1)
Hoth Therapeutics, Inc. (10)
IMARA Inc. (4)
INNOVATE BIOPHARMACEUTICALS, INC. (5)
Innoviva, Inc. (2)
IntelGenx Technologies Corp. (2)
Intersect ENT, Inc. (8)
Intra-Cellular Therapies, Inc. (2)
Iterum Therapeutics plc (2)
Jaguar Health, Inc. (15)
Jazz Pharmaceuticals plc (10)
Johnson & Johnson (2)
Kala Pharmaceuticals, Inc. (2)
Kaleido Biosciences, Inc. (3)
Kannalife Inc (9)
KEMPHARM, INC (5)
Lannett Company, Inc. (2)
Level Brands, Inc. (6)
Lexaria Bioscience Corp. (3)
Lipocine Inc. (1)
Liquidia Corp (8)
Liquidia Technologies Inc (1)
Lyra Therapeutics, Inc. (3)
Mallinckrodt (6)
Marijuana Co of America, Inc. (3)
MARINUS PHARMACEUTICALS INC (2)
MedGen, Inc. (3)
Medicine Man Technologies, Inc. (4)
Menlo Therapeutics Inc. (7)
Merck (2)
MICROCHANNEL TECHNOLOGIES CORP (44)
Milestone Pharmaceuticals Inc. (5)
MJ Holdings, Inc. (3)
Mylan N.V. (6)
MYnd Analytics, Inc. (9)
MyoKardia Inc (1)
Nabriva Therapeutics plc (4)
NEKTAR THERAPEUTICS (3)
Neos Therapeutics, Inc. (3)
NewBridge Global Ventures, Inc. (2)
NGM BIOPHARMACEUTICALS INC (5)
Notis Global, Inc. (2)
NovaBay Pharmaceuticals, Inc. (8)
Novan, Inc. (4)
OCULAR THERAPEUTIX, INC (1)
Odonate Therapeutics, Inc. (3)
OMEROS CORP (1)
Onconova Therapeutics, Inc. (1)
OPIANT PHARMACEUTICALS, INC. (5)
OptiNose, Inc. (1)
ORAMED PHARMACEUTICALS INC. (3)
Osmotica Pharmaceuticals plc (4)
OTONOMY, INC. (1)
Pacira Pharmaceuticals, Inc. (1)
Panacea Acquisition Corp (13)
Paratek Pharmaceuticals, Inc. (8)
Perrigo (3)
Pfizer (13)
Phathom Pharmaceuticals, Inc. (3)
Phibro Animal Health Corporation (1)
Pivot Pharmaceuticals Inc. (2)
PLAYERS NETWORK (1)
PLIANT THERAPEUTICS, INC. (7)
PLx Pharma Inc. (2)
Prestige Brands Holdings Inc (2)
Processa Pharmaceuticals, Inc. (4)
PROTEO INC (3)
PROVECTUS BIOPHARMACEUTICALS, INC. (3)
Provention Bio, Inc. (2)
Pulmatrix, Inc. (4)
QUANTA INC (4)
REATA PHARMACEUTICALS INC (1)
Recro Pharma, Inc. (4)
RELMADA THERAPEUTICS, INC. (5)
RespireRx Pharmaceuticals Inc. (6)
resTORbio, Inc. (5)
Revance Therapeutics, Inc. (4)
Royalty Pharma plc (5)
Satsuma Pharmaceuticals, Inc. (4)
Scopus BioPharma Inc. (2)
scPharmaceuticals Inc. (2)
SCYNEXIS INC (3)
SenesTech, Inc. (2)
SIGA TECHNOLOGIES INC (2)
Sonoma Pharmaceuticals, Inc. (3)
Stem Holdings, Inc. (1)
Strongbridge Biopharma plc (5)
SUNWIN STEVIA INTERNATIONAL, INC. (1)
Supernus Pharmaceuticals, Inc. (1)
Target Group Inc. (4)
Teligent, Inc. (1)
Tenzing Acquisition Corp. (9)
Terra Tech Corp. (18)
TETRAPHASE PHARMACEUTICALS INC (11)
TEVA PHARMACEUTICAL INDUSTRIES LTD (2)
Textmunication Holdings, Inc. (4)
TFF Pharmaceuticals, Inc. (1)
TherapeuticsMD, Inc. (1)
Theravance Biopharma, Inc. (6)
Tilray, Inc. (12)
TITAN PHARMACEUTICALS INC (1)
Trevi Therapeutics, Inc. (4)
Tricida, Inc. (1)
Trulieve Cannabis Corp. (1)
Urovant Sciences Ltd. (3)
Verona Pharma plc (2)
Verrica Pharmaceuticals Inc. (1)
Vireo Health International, Inc. (1)
VIVUS INC (9)
Wave Life Sciences Ltd. (1)
Wize Pharma, Inc. (7)
XERIS PHARMACEUTICALS INC (3)
Zoetis (5)
ZOGENIX, INC. (2)
Zomedica Pharmaceuticals Corp. (3)
Zynerba Pharmaceuticals, Inc. (2)

Recent Contracts

Cash Continuity Arrangement between Endo and George Apostol, dated November 5, 2020 (Endo International plc, Filed With SEC on May 7, 2021)
Offer Letter Agreement, by and between the Registrant and Hsiao D. Lieu, M.D., dated as of January 16, 2019 (NGM BIOPHARMACEUTICALS INC, Filed With SEC on May 6, 2021)
Offer Letter Agreement, by and between the Registrant and Valerie L. Pierce, dated as of August 6, 2019, and related information (NGM BIOPHARMACEUTICALS INC, Filed With SEC on May 6, 2021)
Offer Letter, dated as of April 7, 2021, by and between Andrew Saik and VYNE Pharmaceuticals Inc (Menlo Therapeutics Inc., Filed With SEC on May 6, 2021)
Offer Letter, dated as of April 7, 2021, by and between Mutya Harsch and VYNE Pharmaceuticals Inc (Menlo Therapeutics Inc., Filed With SEC on May 6, 2021)
Open Market Sale AgreementSM, dated May 6, 2021, by and between Nabriva Therapeutics plc and Jefferies LLC (Nabriva Therapeutics plc, Filed With SEC on May 6, 2021)
Complaint dated March 19, 2021 (MJ Holdings, Inc., Filed With SEC on April 21, 2021)
Description of Registrants Securities (RespireRx Pharmaceuticals Inc., Filed With SEC on April 15, 2021)
Commission Agreement with Andrew Holtmeyer (Canbiola, Inc., Filed With SEC on April 14, 2021)
Asset Acquisition Agreement with Imbibe (Canbiola, Inc., Filed With SEC on April 14, 2021)